Retracted COVID-19 studies expose holes in vetting of data firms

The scramble to research the novel coronavirus has exposed weaknesses in the vetting of healthcare data being supplied by a growing number of U.S. firms, a flaw that forced two of the most respected medical journals to pull studies last week.

from Reuters: World News https://ift.tt/37gcLPf